Health Care & Life Sciences » Biotechnology | Japan Tissue Engineering Co. Ltd.

Japan Tissue Engineering Co. Ltd. | Ownership

Companies that own Japan Tissue Engineering Co. Ltd.

Name
Shares Held
% Shares Out
Change In Shares
% of Assets
As of Date
Asset Management One Co., Ltd.
162,199
0.4%
-45,301
0%
01/15/2018
Mitsubishi UFJ Kokusai Asset Management Co., Ltd.
33,699
0.08%
33,699
0%
02/26/2018
Sawakami Asset Management, Inc.
19,999
0.05%
-1
0.01%
08/23/2017
BlackRock Advisors (UK) Ltd.
14,900
0.04%
0
0%
09/06/2018
SSgA Funds Management, Inc.
9,800
0.02%
0
0%
09/06/2018
TIAA-CREF Investment Management LLC
8,500
0.02%
0
0%
03/31/2018
BlackRock Fund Advisors
7,400
0.02%
0
0%
09/06/2018
Guardians of New Zealand Superannuation
7,000
0.02%
6,200
0%
06/30/2017
Astmax Asset Management, Inc.
4,299
0.01%
4,299
0.04%
11/10/2017
The Vanguard Group, Inc.
3,200
0.01%
-3,200
0%
07/31/2018

About Japan Tissue Engineering Co.

View Profile
Address
6-209-1 Miyakitadori
Gamagori Aichi 443
Japan
Employees -
Website http://www.jpte.co.jp
Updated 09/14/2018
Japan Tissue Engineering Co., Ltd. engages in the research, development, and manufacture of cultured biological cells and tissues. It operates through the Regenerative Medicine, Custom Development and Manufacturing, and Research and Development (R&D) Support segments. The Regenerative Medicine segment develops, manufactures, and sells tissue-engineered medical products through autologous culturing techniques.